Archives of Gynecology and Obstetrics

, Volume 277, Issue 3, pp 245–248

Relationship between obstetric history and Rh(D) alloimmunization severity

Original Article



To evaluate the relationship between obstetric history and Rh(D) alloimmunization severity, employing the gestational age at the first intrauterine fetal transfusion (IUT) as an indicator of this severity.


From 1996 to 2006, Rh(D) alloimmunized pregnancies submitted to IUT had their data assessed. Gestational age at the first IUT was modeled as a linear outcome. The associations between obstetric history variables, anti-Rh(D) antibodies titer and gestational age at the first IUT were analyzed. Statistics are presented with 95% confidence intervals (< 0.05).


A total of 82 non-hydropic anemic fetuses, ensuing in 92.7% (n = 76) of perinatal survival, were submitted to IUT. Nineteen (23,2%) pregnant women did not present with any previous stillbirth, neonatal death, IUT, hydrops or neonatal exchange transfusion (group 1); and 63 (76.8%) reported at least one of these events (group 2). Gestational age at the first IUT differed significantly between the groups (P = 0.0001). For group 1, it ranged from 24 to 35 weeks (median 32.5 weeks), whereas for group 2 it ranged from 19 to 34 weeks (median 27 weeks). In the multivariated analysis, previous neonatal death (= 0.040), previous IUT (= 0.000) and previous neonatal exchange transfusion (= 0.036) were independently associated with the gestational age at the first IUT.


The evaluation of the obstetrical history is an important diagnostic tool for predicting Rh(D) alloimmunization severity. Alloimmunized pregnant women who reported previous neonatal death(s), neonatal exchange transfusion(s) or IUT(s) should receive a closer fetal surveillance due to the risk of a higher rate of fetal hemolysis and the need of an earlier IUT.


Alloimmunization Fetal anemia Fetal hydrops Fetal therapy Intrauterine transfusion Perinatal loss 


  1. 1.
    Amorim L, Ximenes GV, Susana TC, Mello SM, Castilho SL, Lopes MED (2003) Reasons for anti-D alloimmunization in Brazilian blood donors. Transfusion 43:96AGoogle Scholar
  2. 2.
    Armitage P, Mollison L (1953) Further analysis of controlled trials of treatment of hemolytic disease of the newborn. J Obstet Gynecol Br Emp 60:605–620Google Scholar
  3. 3.
    Bowman JM (1999) Hemolytic disease (erythroblastosis fetalis). In: Creasy RK, Resnik R (eds) Maternal fetal medicine, 4th edn. W B Sanders, Philadelphia, p 736Google Scholar
  4. 4.
    Chavez GFJ, Mulinare J, Edmonds LD (1991) Epidemiology of Rh hemolytic disease of the newborn in the United States. JAMA 265:3270–3274PubMedCrossRefGoogle Scholar
  5. 5.
    Hughes RG, Craig JIO, Murphy WG, Greer IA (1994) Causes and clinical consequences of Rhesus (D) haemolytic disease of the newborn: a study of a Scottish population, 1985–1990. Br J Obstet Gynaecol 101:297–300PubMedGoogle Scholar
  6. 6.
    Liley AW (1961) Liquor amnii analysis in the management of the pregnancy complicated by Rhesus sensitization. Am J Obstet Gynecol 82:1359–1370PubMedGoogle Scholar
  7. 7.
    Mari G (2005) Middle cerebral artery peak systolic velocity: is it the standard of care for the diagnosis of fetal anemia? J Ultrasound Med 24:697–702PubMedGoogle Scholar
  8. 8.
    Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, Dorman KF, Ludomirsky A, Gonzalez R, Gomez R, Oz U, Detti L, Copel JA, Bahado-Singh R, Berry S, Martinez-Poyer J, Blackwell SC (2000) Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red cell alloimmunization. Collaborative group for Doppler assessment of the blood velocity in anemic fetuses. N Engl J Medicine 342:9–14CrossRefGoogle Scholar
  9. 9.
    Mari G, Detti L, Oz U, Zimmerman R, Duerig P, Stefos T (2002) Accurate prediction of fetal hemoglobin by Doppler ultrasonography. Obstet Gynecol 99:589–593PubMedCrossRefGoogle Scholar
  10. 10.
    Mari G, Zimmerman R, Moise KJ Jr, Deter RL (2005) Correlation between middle cerebral artery peak systolic velocity and fetal hemoglobin after two previous intrauterine transfusions. Am J Obstet Gynecol 193:1117–1120PubMedCrossRefGoogle Scholar
  11. 11.
    Martin JA, Hamilton BE, Ventura SJ, Menacker F, Park MM, Sutton PD (2002) Births: final data for 2001. Natl Vital Stat Rep 18:1–102Google Scholar
  12. 12.
    McSweeney E, Kirkham J, Vinall P, Flanagan P (1998) An audit of anti-D sensitisation in Yorkshire. Br J Obstet Gynaecol 105:1091–1094PubMedGoogle Scholar
  13. 13.
    Moise KJ Jr (2002) Management of Rhesus alloimmunization in pregnancy. Obstet Gynecol 100:600–611. Erratum in: Obstet Gynecol, 100:833PubMedCrossRefGoogle Scholar
  14. 14.
    Nardozza LMM, Moron AF, Junior EA, Camano L, Chinen PA, Torloni MR (2007) Rh alloimmunization: Doppler or amniotic fluid analysis in the prediction of fetal anemia? Arch Gynecol Obstet 275:107–111PubMedCrossRefGoogle Scholar
  15. 15.
    Oepkes D, Seaward PG, Vandenbussche FP, Windrim R, Kingdom J, Beyene J, Kanhai HH, Ohlsson A, Ryan G; DIAMOND Study Group (2006) Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 355:156–164PubMedCrossRefGoogle Scholar
  16. 16.
    Queenan JT (2002) Rh-disease: a perinatal success story. Obstet Gynecol 100:405–406CrossRefGoogle Scholar
  17. 17.
    Rodeck CH, Nicolaides KH, Warsof SL, Fysh WJ, Gamsu RH, Kemp RJ (1984) The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions. Am J Obstet Gynecol 150:769–774PubMedGoogle Scholar
  18. 18.
    Silver RM, Varner MW, Reddy U, Goldenberg R, Pinar H, Conway D, Bukowski R, Carpenter M, Hogue C, Willinger M, Dudley D, Saade G, Stoll B (2007) Work-up of stillbirth: a review of the evidence. Am J Obstet Gynecol 196:433–444PubMedCrossRefGoogle Scholar
  19. 19.
    van Kamp IL, Klumper FJ, Meerman RH, Oepkes D, Scherjon SA, Kanhai HH (2004) Treatment of fetal anemia due to red cell alloimmunization with intrauterine transfusions in the Netherlands, 1988–1999. Acta Obstet Gynecol Scand 83:731–737PubMedCrossRefGoogle Scholar
  20. 20.
    Whitfield CR, Raafat A, Urbaniak SJ (1997) “Underreporting of mortality from RhD haemolytic disease in Scotland and its implications: retrospective review. Br Med J 315:1504–1505Google Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Fetal Medicine Unit, Department of Obstetrics, Fernandes Figueira InstituteOswaldo Cruz Foundation (IFF-FIOCRUZ)Rio de Janeiro (RJ)Brazil

Personalised recommendations